Company intelligence / Profile preview

Alvalux Medical

Mont-Saint-Guibert, Belgium

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Alvalux Medical is a Belgian medical technology company specializing in wearable light therapy solutions for ophthalmic conditions. The company's flagship product, C-LYTE, is a non-invasive, wearable device designed to treat Dry Eye Disease caused by Meibomian Gland Dysfunction (MGD) using photobiomodulation. By delivering controlled light therapy directly to the eyelids, the device aims to improve tear film quality and patient comfort. Alvalux focuses on miniaturizing complex clinical technologies into portable, home-use formats to enhance patient compliance and clinical outcomes.

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Alvalux Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alvalux Medical.

Explore the full profile